Handel nachbörslich: 29.55

Galapagos NV ADR (GLPG)

Galapagos NV ADR Aktie (GLPG) Neueste Nachrichten

Galapagos NV ADR (GLPG)

Galapagos NV ADR Aktie (GLPG) Neueste Nachrichten

Galapagos creates new subscription right plans

Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.

Are Medical Stocks Lagging Galapagos (GLPG) This Year? - Yahoo Singapore News

Earnings call: Galapagos outlines strategic focus in Q1 2024 results - Investing.com

Biotech Stock Roundup: ALXN Up on Acquisition News, PFE-BNTX Get EUA for Vaccine & More - Yahoo News UK

Galapagos’ aandeelhouders keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de jaarlijkse Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen 2024

Down -9.97% in 4 Weeks, Here's Why You Should You Buy the Dip in Galapagos (GLPG)

Bristol Myers (BMY) Reports Positive Colorectal Cancer Study Data

Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%

After Plunging -7.94% in 4 Weeks, Here's Why the Trend Might Reverse for Galapagos (GLPG)

Bristol Myers (BMY) Wins EC Nod for Reblozyl Label Expansion

Disc Medicine (IRON) Down on Mixed Results From AURORA Study

Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why

Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst

Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings

Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding

Praxis (PRAX) Surges on Positive Epilepsy Study Results

Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur

Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA

Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec

Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal

Bayer's (BAYRY) Elinzanetant Meets Goals in Third Phase III Study

Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround

Galapagos announces full year 2023 results and outlook for 2024

Galapagos presenteert op de jaarlijkse EBMT-EHA meeting van 2024

Galapagos completes transaction to transfer Jyseleca® business to Alfasigma

Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

Galapagos gaat een strategische samenwerking aan met BridGene Biosciences om de ontdekking van kleine moleculegeneesmiddelen in oncologie uit te breiden

Galapagos signs agreement to transfer Jyseleca® business to Alfasigma

FDA Rejects Amgen's (AMGN) NDA Seeking Full Nod for Lumakras

Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy

Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals

Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA

FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab

Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301

Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer

FDA Expands Merck's (MRK) Welireg Label in Renal Cell Carcinoma

Moderna (MRNA) Soars on Upbeat Data From Cancer Therapy Study

Buy These 4 Low-Beta Stocks to Counter Market Volatility

FDA Updates Labels of Esperion's (ESPR) Cholesterol-Lowering Drugs

Best Momentum Stocks to Buy for December 13th

New Strong Buy Stocks for December 13th

Galapagos presenteert nieuwe bemoedigende resultaten op ASH 2023 voor lopende CD19 CAR-T studies met GLPG5201 en GLPG5101

Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023

Morgan Stanley lists biotechs with negative enterprise value, 2022 catalysts (NASDAQ:GLPG) - Seeking Alpha

Galapagos Begins Dosing With GLPG3970 in Psoriasis Study - Yahoo Singapore News

The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs - Benzinga

The 5 Best-Performing Non-S&P Stocks of 2015 - Forbes

Ähnlich wie GLPG